Stockscreener 앱 받기
9.55
2.91%
0.27
전일 마감가:
$9.28
열려 있는:
$9.56
하루 거래량:
2.33M
Relative Volume:
0.47
시가총액:
$1.64B
수익:
$1.84M
순이익/손실:
$-118.44M
주가수익비율:
-11.52
EPS:
-0.8291
순현금흐름:
$-98.51M
1주 성능:
+4.03%
1개월 성능:
+14.78%
6개월 성능:
+260.38%
1년 성능:
+273.05%
1일 변동 폭
$9.50
$9.90
1주일 범위
$8.55
$10.03
52주 변동 폭
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
명칭
Absci Corp
전화
(360) 949-1041
주소
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
9.55 | 1.59B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | 개시 | JP Morgan | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-01-22 | 개시 | Needham | Buy |
| 2024-10-02 | 개시 | Guggenheim | Buy |
| 2024-07-03 | 개시 | Morgan Stanley | Overweight |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 개시 | H.C. Wainwright | Buy |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 개시 | Truist | Buy |
| 2022-03-02 | 재개 | Cowen | Market Perform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-11-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-08-16 | 개시 | BofA Securities | Neutral |
| 2021-08-16 | 개시 | Cowen | Market Perform |
| 2021-08-16 | 개시 | Credit Suisse | Outperform |
| 2021-08-16 | 개시 | Stifel | Hold |
모두보기
Absci Corp 주식(ABSI)의 최신 뉴스
Absci (NASDAQ:ABSI) Shares Gap UpShould You Buy? - MarketBeat
Morgan Stanley Maintains Absci Corp(ABSI.US) With Hold Rating, Raises Target Price to $10 - 富途牛牛
Absci (ABSI) Q2 2026 Earnings Call Transcript - AOL.com
Ransi Mudalinayake Somaratne Net Worth (2026) - GuruFocus
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma - The Globe and Mail
ABSI Looks 1092.2% Overvalued on GF Value™ - GuruFocus
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.4%Here's Why - MarketBeat
Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely? - Moomoo
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corp. Earnings Call Highlights ABS-201 And Cash - The Globe and Mail
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $11 to $16 - Moomoo
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation - Yahoo Finance
Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings - simplywall.st
Absci (NASDAQ:ABSI) Shares Gap Down After Earnings Miss - marketbeat.com
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
BTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? - Yahoo Finance
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - Moomoo
ABSI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Absci Q2 2026 Earnings Call Transcript - MarketBeat
Absci Q2 Loss Narrows, Revenue Declines - Moomoo
Why is Absci stock tumbling today? - Investing.com
ABSI Looks 934.1% Overvalued on GF Value™ - GuruFocus
Absci Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Absci misses Q2 2026 estimates as stock falls after hours - Investing.com Nigeria
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Why is Absci stock tumbling today? By Investing.com - Investing.com Nigeria
Absci Q2 Earnings Call Highlights - MarketBeat
Absci earnings missed by $0.02, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Absci shares tumble on earnings miss, weak revenue - Investing.com
Absci set to report earnings as partnership revenue surges By Investing.com - Investing.com UK
Absci shares tumble on earnings miss, weak revenue By Investing.com - Investing.com South Africa
Absci Corp 2026: Revenue $318K, EPS ($0.21) — 10-Q Summary - TradingView
Absci Corporation (NASDAQ: ABSI) boosts cash to $201M while net loss deepens - Stock Titan
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results - Yahoo! Finance Canada
ABSI Archives - 24/7 Wall St.
Absci set to report earnings as partnership revenue surges - Investing.com
ABSI Looks 881.3% Overvalued on GF Value™ - GuruFocus
Earnings To Watch: Absci Corp (ABSI) Q2 2026 -- GF Value Sees 92% Downside - GuruFocus
Absci Corp expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Absci Corp (ABSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Absci Corp (ABSI) Stock News Today - TradingKey
Earnings Preview: Absci Corp to Report Financial Results Post-market on August 11 - Moomoo
Absci Corp (ABSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
1.07%
자본화:
|
볼륨(24시간):